Clover Health officer proposes roughly $284K share sale
The notice also lists three prior plan sales during the preceding three months, including 318,806 shares on October 1.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Andrew Toy, an officer of Clover Health Investments, Corp. (CLOV), gave notice of a proposed sale of 60,765 Class A common shares for October 15, 2026, with an approximate market value of $284,380.2. The proposed sale is intended to cover tax withholding obligations tied to restricted stock unit vesting and settlement; the remarks say it is not discretionary. Prior three-month sales listed were 62,711 shares on July 15, 87,798 on August 10, and 318,806 on October 1, each identified as a 10b5-1 plan sale.
Key Figures
Key Terms
restricted stock units financial
sell to cover financial
10b5-1 Plan Sale regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.